Solventum Corp

SOLV NYSE CIK: 0001964738

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filer
State of Incorporation DE
Business Address C/O 3M COMPANY, ST. PAUL, MN, 55144-1000
Mailing Address C/O 3M COMPANY, ST. PAUL, MN, 55144-1000
Phone 651-733-1110
Fiscal Year End 1231
EIN 922008841

Financial Overview

FY2024

$14.46B
Total Assets
$12.06B
Stockholders' Equity
$762.00M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report February 3, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 27, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
8-K Current report of material events December 16, 2025 View on SEC
4 Insider stock transaction report December 3, 2025 View on SEC
4 Insider stock transaction report December 2, 2025 View on SEC
4 Insider stock transaction report December 2, 2025 View on SEC
4 Insider stock transaction report November 18, 2025 View on SEC
3 Initial insider ownership report November 18, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment November 13, 2025 View on SEC

Material Events

8-K Strategy Change December 16, 2025
High Impact
  • Solventum Corp issued a letter to shareholders detailing significant progress in its first year as a standalone public company.
  • The company launched a long-range plan, achieved six consecutive quarters of positive sales growth, and raised its financial outlook.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.